-
公开(公告)号:US08273773B2
公开(公告)日:2012-09-25
申请号:US12460658
申请日:2009-07-22
申请人: Kenneth Albert Brameld , David Scott Carter , Elbert Chin , Javier de Vicente Fidalgo , Jim Li , Ryan Craig Schoenfeld , Eric Brian Sjogren , Francisco Xavier Talamas
发明人: Kenneth Albert Brameld , David Scott Carter , Elbert Chin , Javier de Vicente Fidalgo , Jim Li , Ryan Craig Schoenfeld , Eric Brian Sjogren , Francisco Xavier Talamas
IPC分类号: A61K31/4412 , C07D213/64
CPC分类号: C07D213/64 , C07D401/10 , C07D401/12 , C07D405/04 , C07D405/10 , C07D409/10 , C07D413/10
摘要: Compounds having the formula I wherein R1, R2, R3, R4a, R4b, R4c, R5, R6, R9 and n are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
摘要翻译: 具有式I的化合物,其中R1,R2,R3,R4a,R4b,R4c,R5,R6,R9和n如本文所定义,是丙型肝炎病毒NS5b聚合酶抑制剂。 还公开了用于治疗HCV感染和抑制HCV复制的组合物和方法。
-
公开(公告)号:US20100021423A1
公开(公告)日:2010-01-28
申请号:US12460658
申请日:2009-07-22
申请人: Kenneth Albert Brameld , David Scott Carter , Elbert Chin , Javier de Vicente Fidalgo , Jim Li , Ryan Craig Schoenfeld , Eric Brian Sjogren , Francisco Xavier Talamas
发明人: Kenneth Albert Brameld , David Scott Carter , Elbert Chin , Javier de Vicente Fidalgo , Jim Li , Ryan Craig Schoenfeld , Eric Brian Sjogren , Francisco Xavier Talamas
IPC分类号: A61K38/20 , A61K38/21 , C12N5/02 , A61K38/17 , A61K31/4412 , C07D213/63
CPC分类号: C07D213/64 , C07D401/10 , C07D401/12 , C07D405/04 , C07D405/10 , C07D409/10 , C07D413/10
摘要: Compounds having the formula I wherein R1, R2, R3, R4a, R4b, R4c, R5, R6, R9 and n are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
摘要翻译: 具有式I的化合物,其中R1,R2,R3,R4a,R4b,R4c,R5,R6,R9和n如本文所定义,是丙型肝炎病毒NS5b聚合酶抑制剂。 还公开了用于治疗HCV感染和抑制HCV复制的组合物和方法。
-
公开(公告)号:US08158631B2
公开(公告)日:2012-04-17
申请号:US12822630
申请日:2010-06-24
申请人: Elbert Chin , Javier de Vicente Fidalgo , Jim Li , Alfred Sui-Ting Lui , Kristen Lynn McCaleb , Ryan Craig Schoenfeld , Francisco Xavier Talamas
发明人: Elbert Chin , Javier de Vicente Fidalgo , Jim Li , Alfred Sui-Ting Lui , Kristen Lynn McCaleb , Ryan Craig Schoenfeld , Francisco Xavier Talamas
IPC分类号: A61K31/497 , C07D241/02
CPC分类号: C07D239/10 , C07D207/26 , C07D207/44 , C07D233/34 , C07D237/14 , C07D239/36 , C07D241/18 , C07D249/12 , C07D275/06 , C07D285/16
摘要: Compounds having the formula I wherein R1, R2, R3, R4, and R5 are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
摘要翻译: 具有式I的化合物,其中R 1,R 2,R 3,R 4和R 5如本文所定义,是丙型肝炎病毒NS5b聚合酶抑制剂。 还公开了用于治疗HCV感染和抑制HCV复制的组合物和方法。
-
公开(公告)号:US20110300103A1
公开(公告)日:2011-12-08
申请号:US13212742
申请日:2011-08-18
申请人: Javier de Vicente Fidalgo , Jim Li , Ryan Craig Schoenfeld , Francisco Xavier Talamas , Joshua Paul Gergely Taygerly
发明人: Javier de Vicente Fidalgo , Jim Li , Ryan Craig Schoenfeld , Francisco Xavier Talamas , Joshua Paul Gergely Taygerly
IPC分类号: A61K31/4709 , A61K31/513 , A61K31/501 , A61K31/4439 , A61P31/14 , A61K31/502 , A61K38/21 , A61K38/20 , A61K38/19 , C12N5/00 , A61K31/498 , A61K31/4725
CPC分类号: C07D403/10 , C07D213/69 , C07D239/46 , C07D401/04 , C07D401/10 , C07D401/14
摘要: Method for treating an HCV infection and inhibiting HCV replication with a compound of formula I wherein R1, R2, R3, R4, X1, X2, X3 and X4 and as defined herein
摘要翻译: 用式I化合物治疗HCV感染和抑制HCV复制的方法,其中R 1,R 2,R 3,R 4,X 1,X 2,X 3和X 4如本文所定义
-
公开(公告)号:US08026253B2
公开(公告)日:2011-09-27
申请号:US12797308
申请日:2010-06-09
申请人: Javier de Vicente Fidalgo , Jim Li , Ryan Craig Schoenfeld , Francisco Xavier Talamas , Joshua Paul Gergely Taygerly
发明人: Javier de Vicente Fidalgo , Jim Li , Ryan Craig Schoenfeld , Francisco Xavier Talamas , Joshua Paul Gergely Taygerly
IPC分类号: A61K31/47
CPC分类号: C07D403/10 , C07D213/69 , C07D239/46 , C07D401/04 , C07D401/10 , C07D401/14
摘要: Compounds having the formula I wherein wherein R1, R2, R3, R4, X1, X2, X3 and X4 and as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
摘要翻译: 具有式I的化合物,其中R 1,R 2,R 3,R 4,X 1,X 2,X 3和X 4如本文所定义是丙型肝炎病毒NS5b聚合酶抑制剂。 还公开了用于治疗HCV感染和抑制HCV复制的组合物和方法。
-
公开(公告)号:US08487103B2
公开(公告)日:2013-07-16
申请号:US13212742
申请日:2011-08-18
申请人: Javier de Vicente Fidalgo , Jim Li , Ryan Craig Schoenfeld , Francisco Xavier Talamas , Joshua Paul Gergely Taygerly
发明人: Javier de Vicente Fidalgo , Jim Li , Ryan Craig Schoenfeld , Francisco Xavier Talamas , Joshua Paul Gergely Taygerly
IPC分类号: C07D215/00
CPC分类号: C07D403/10 , C07D213/69 , C07D239/46 , C07D401/04 , C07D401/10 , C07D401/14
摘要: Method for treating an HCV infection and inhibiting HCV replication with a compound of formula I wherein R1, R2, R3, R4, X1, X2, X3 and X4 and as defined herein
摘要翻译: 用式I化合物治疗HCV感染和抑制HCV复制的方法,其中R 1,R 2,R 3,R 4,X 1,X 2,X 3和X 4如本文所定义
-
公开(公告)号:US20100311760A1
公开(公告)日:2010-12-09
申请号:US12797308
申请日:2010-06-09
申请人: Javier de Vicente Fidalgo , Jim Li , Ryan Craig Schoenfeld , Francisco Xavier Talamas , Joshua Paul Gergely Taygerly
发明人: Javier de Vicente Fidalgo , Jim Li , Ryan Craig Schoenfeld , Francisco Xavier Talamas , Joshua Paul Gergely Taygerly
IPC分类号: A61K31/495 , A61K31/506 , C07D401/02 , C07D401/14 , A61K31/4709 , A61K31/47 , C07D217/00 , C07D237/28 , A61K31/50 , C07D241/36 , A61P31/12
CPC分类号: C07D403/10 , C07D213/69 , C07D239/46 , C07D401/04 , C07D401/10 , C07D401/14
摘要: Compounds having the formula I wherein wherein R1, R2, R3, R4, X1, X2, X3 and X4 and as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
摘要翻译: 具有式I的化合物,其中R 1,R 2,R 3,R 4,X 1,X 2,X 3和X 4如本文所定义是丙型肝炎病毒NS5b聚合酶抑制剂。 还公开了用于治疗HCV感染和抑制HCV复制的组合物和方法。
-
公开(公告)号:US08178547B2
公开(公告)日:2012-05-15
申请号:US12636999
申请日:2009-12-14
IPC分类号: A01N43/54
CPC分类号: C07D405/04 , C07D237/14 , C07D239/36 , C07D239/52 , C07D239/54 , C07D241/18 , C07D253/07
摘要: Compounds having the formula I wherein A, R1, R2, R3, R4a, R4b, R4c, R5, R6, R7a, R7b, Ar1, Rc, Rd, Re, Rf, X, n and p are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
摘要翻译: 具有式I的化合物,其中A,R1,R2,R3,R4a,R4b,R4c,R5,R6,R7a,R7b,Ar1,Rc,Rd,Re,Rf,X,n和p如本文所定义是丙型肝炎 病毒NS5b聚合酶抑制剂。 还公开了用于治疗HCV感染和抑制HCV复制的组合物和方法。
-
公开(公告)号:US08063072B2
公开(公告)日:2011-11-22
申请号:US12887450
申请日:2010-09-21
IPC分类号: A01N43/40 , A61K31/44 , C07D421/00
CPC分类号: C07D213/64 , C07D213/85 , C07D401/04
摘要: Compounds having the formula I wherein R1, R2, R3, R4, and R5 are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
摘要翻译: 具有式I的化合物,其中R 1,R 2,R 3,R 4和R 5如本文所定义,是丙型肝炎病毒NS5b聚合酶抑制剂。 还公开了用于治疗HCV感染和抑制HCV复制的组合物和方法。
-
公开(公告)号:US20110136864A1
公开(公告)日:2011-06-09
申请号:US12957745
申请日:2010-12-01
IPC分类号: A61K31/475 , C07D405/10 , A61P25/22 , A61P25/24
CPC分类号: C07D401/04
摘要: Compounds of the formula: or pharmaceutically acceptable salts thereof, wherein m, n, R1, R2, R3, R4 and R5 are defined herein. Also provided are pharmaceutical compositions, methods of using, and methods of preparing the compounds.
摘要翻译: 其中m,n,R 1,R 2,R 3,R 4和R 5在本文中定义的式的化合物或其药学上可接受的盐。 还提供药物组合物,使用方法和制备化合物的方法。
-
-
-
-
-
-
-
-
-